You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
The Cutting Edge Low-Dose Bexarotene and Low-Dose Interferon Alfa-2b for Adult T-Cell Leukemia/Lymphoma Associated With Human T-Lymphotropic Virus 1
Stephen Richardson; Jeanne B. Budgin; Jacqueline M. Junkins-Hopkins; Carmela C. Vittorio; Jason Lee; Wallace T. Miller Jr; Alain H. Rook; Ellen J. Kim
Arch Dermatol 2005; 141: 301-304.
[Extract][Full text][PDF]
Studies Long-term Follow-up of Patients With Early-Stage Cutaneous T-Cell Lymphoma Who Achieved Complete Remission With Psoralen Plus UV-A Monotherapy
Christiane Querfeld; Steven T. Rosen; Timothy M. Kuzel; Katharine A. Kirby; Henry H. Roenigk Jr; Bettina M. Prinz; Joan Guitart
Arch Dermatol 2005; 141: 305-311.
[Abstract][Full text][PDF]
Studies Biological Effects of Bexarotene in Cutaneous T-Cell Lymphoma
Jeanne B. Budgin; Stephen K. Richardson; Sarah B. Newton; Maria Wysocka; Mohamed H. Zaki; Bernice Benoit; Alain H. Rook
Arch Dermatol 2005; 141: 315-320.
[Abstract][Full text][PDF]
Studies Health-Related Quality-of-Life Assessment in Patients With Cutaneous T-Cell Lymphoma
Marie-France Demierre; Amy Tien; Donald Miller
Arch Dermatol 2005; 141: 325-330.
[Abstract][Full text][PDF]
Observations Mycosis Fungoides–Type Cutaneous T-Cell Lymphoma and Neutrophilic Dermatosis
Nathalie Franck; Agnes Carlotti; Isabelle Gorin; Marc Buffet; Christine Mateus; Nicolas Dupin; for the French Study Group on Cutaneous Lymphomas
Arch Dermatol 2005; 141: 353-356.
[Abstract][Full text][PDF]
Observations Monoclonal T-Cell Dyscrasia of Undetermined Significance Associated With Recalcitrant Erythroderma
